AQR Capital Management - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$186,568
-74.9%
74,927
-73.0%
0.00%
-100.0%
Q1 2023$742,644
+53.8%
277,106
+1207.8%
0.00%
+100.0%
Q3 2019$483,000
+49.5%
21,188
+9.0%
0.00%
Q1 2019$323,000
-48.1%
19,447
-40.1%
0.00%
-100.0%
Q4 2018$622,000
-37.6%
32,475
+70.5%
0.00%0.0%
Q3 2018$996,000
+114.7%
19,051
+78.5%
0.00%
Q2 2018$464,00010,6700.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders